ParcelBio
YC W24Elevated mRNA for transformative medicines.
San Francisco, CA, USAFounded 20246 employeesparcelbio.com
Team
6
Founded
2024
About
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
No open roles at this time.
Similar Healthcare startups
Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
BiotechHealthcareTherapeutics
Open Jobs —
Team 5
Founded 2024
Granza Bio
Building programmable therapeutics for the immune system
Synthetic BiologyBiotechHealthcare
Open Jobs —
Team 7
Founded 2024
Engage Bio
Potent, durable, and redosable non-viral genetic medicines
Synthetic BiologyBiotechHealthcare
Open Jobs —
Team 10
Founded 2022
64x Bio
Enabling next generation medicines. A comprehensive platform and…
Gene TherapyMachine Learning
Open Jobs —
Team 25
Founded 2021